• RNA Pol II Inhibition and Active Apoptotic Signaling

  2026-08-22

  Harper et al. show that RNA polymerase II inhibition can trigger apoptosis through active signaling caused by loss of hypophosphorylated RNA Pol IIA, rather than through transcriptional failure alone. Their PDAR framework provides a mechanistic lens for interpreting transcription-targeting drugs and for designing experiments that separate polymerase abundance from transcriptional output.

• Drosophila Keap1–Lamin Control of Nuclear Architecture

  2026-08-21

  Carlson and colleagues identify a functional interaction between Drosophila Keap1 and the B-type lamin Dm0, linking xenobiotic and oxidative-response signaling to nuclear lamina organization and heterochromatin distribution. Their perturbation-based evidence suggests that dKeap1 influences chromatin architecture during development, although the direct molecular interface and broader applicability beyond Drosophila remain unresolved.

• BX795: PDK1 Inhibitor Mechanism and Use

  2026-08-21

  BX795 is an ATP-competitive PDK1 inhibitor with additional TBK1 and IKKε activity, making it useful for dissecting kinase signaling and innate immune response modulation. Its reported cellular growth-inhibition values are in the micromolar range, so biochemical potency, target selectivity, and cell viability should be interpreted separately.

• Cefiderocol Activity in Resistant European Non-Fermenters

  2026-08-20

  This European multicenter study compared cefiderocol with β-lactam/β-lactamase inhibitor combinations against 1,451 clinical Pseudomonas aeruginosa and Acinetobacter spp. isolates, including meropenem-resistant strains. Cefiderocol retained high in vitro activity across most resistant groups, while genomic analysis linked cefiderocol resistance mainly with changes involving iron-uptake pathways and, in many Acinetobacter isolates, acquired β-lactamase genes.

• HOBt (1-Hydroxybenzotriazole) for Reliable Assays

  2026-08-20

  This scenario-based guide explains how HOBt (1-Hydroxybenzotriazole), SKU A7025, supports reproducible peptide and amide bond formation before cell viability, proliferation, and cytotoxicity testing. It connects coupling chemistry, hydration and solubility considerations, assay compatibility, data interpretation, and practical product selection without treating HOBt as a direct cell-assay reagent.

• Spirocyclic POM Analogues Target MmpL3 in TB

  2026-08-19

  This 2024 Bioorganic Chemistry study identifies spirocyclic phenyl oxazole methyl analogues as a new MmpL3-directed anti-tubercular chemotype. Compound 5c combined submicromolar activity against Mycobacterium tuberculosis and resistant clinical isolates with favorable preliminary ADME, pharmacokinetic, and cytotoxicity profiles, while mutant-generation and docking studies supported MmpL3 as its plausible target.

• TET2 Metabolite Binding: A Practical STD NMR Protocol

  2026-08-19

  Zhang, Cheng, and Ye describe an integrated workflow that combines biochemical activity assays with saturation transfer difference NMR to distinguish direct metabolite binding from functional regulation of TET2 dioxygenase. The protocol validates known activators and inhibitors and identifies glyoxylate as a direct TET2-binding metabolite, offering a practical framework for studying metabolism–epigenetics interactions.

• MLN8237 (Alisertib) for Aurora A Research

  2026-08-18

  MLN8237 (Alisertib) enables selective Aurora A perturbation across mitotic, apoptosis, and translational cancer biology workflows. This guide connects dose-response design with the newer Aurora A–SAM–trained immunity axis and provides practical troubleshooting for reproducible assays.

• Biotin-16-UTP: From RNA Labeling to Mechanism

  2026-08-17

  Biotin-16-UTP enables affinity-based RNA detection, purification, and interaction assays. This guide connects biotin-labeled uridine triphosphate chemistry with mechanistic lncRNA research, using RNASEH1-AS1 as a case study in experimental design.

• 1-methyl Adenosine in UHPLC–MS/MS Purine Profiling

  2026-08-17

  A 2024 Analytical Chemistry study established a stable isotope-diluted UHPLC–ESI-MS/MS workflow for accurately measuring 12 purine ribonucleosides, including 10 methylated species. Its combination of ammonium bicarbonate-enhanced ionization, isomer-resolving chromatography, methanol extraction, and solid-phase extraction provides a practical analytical foundation for RNA modification research, cellular metabolomics, and biomarker discovery.

• PD0325901 Workflow for MEK Signaling Studies

  2026-08-16

  PD0325901 provides a practical way to connect MEK pathway blockade with P-ERK loss, cell-cycle changes, apoptosis, and tumor response. This guide translates the inhibitor into reproducible cancer assays while defining a cautious, hypothesis-driven extension to pluripotency research.

• Schwartz’s Framework for Measuring Cancer Drug Response

  2026-08-15

  Hannah R. Schwartz’s dissertation distinguishes drug-induced proliferative arrest from actual cell killing, showing that relative and fractional viability are related but noninterchangeable measures. This framework improves interpretation of cancer drug assays by emphasizing response magnitude, biological composition, and timing rather than relying on a single endpoint.

• ABT-737: Reframing BCL-2 Apoptosis Strategy

  2026-08-15

  ABT-737 is more than a cytotoxicity tool: it is a mechanistic probe for mitochondrial apoptotic dependence, BCL-2 family buffering, and stress-induced non-cell-autonomous resistance. This translational perspective outlines how to use the compound to design stronger oncology experiments and interpret resistance biology.

• Kidney-Targeted Excipients and mRNA Loading

  2026-08-14

  This 2024 Pace University dissertation examines how excipients can address payload saturation in polymeric mesoscale nanoparticles designed for kidney-directed mRNA delivery. By comparing DOTAP, trehalose, and calcium acetate formulations with an original platform, the study connects encapsulation efficiency with particle size, cytotoxicity, uptake, pharmacokinetics, and reporter protein production.

• Ethacridine Lactate in Stem Cell Epigenetics

  2026-08-14

  A translational framework for using Ethacridine lactate monohydrate as a controlled microbial variable in surface ectoderm differentiation studies, with emphasis on YAP-TEAD, super-enhancer regulation, assay integrity, and experimental validation.

479 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page